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Occupational exposure to silica dust has been examined as a possible risk factor with respect to
several systemic autoimmune diseases, including scleroderma, rheumatoid arthritis, systemic lupus
erythematosus, and some of the small vessel vasculitidies with renal involvement (e.g., Wegener
granulomatosis). Crystalline silica, or quartz, is an abundant mineral found in sand, rock, and soil.
High-level exposure to respirable silica dust can cause chronic inflammation and fibrosis in the lung
and other organs. Studies of specific occupational groups with high-level silica exposure (e.g.,
miners) have shown increased rates of autoimmune diseases compared to the expected rates in
the general population. However, some clinic- and population-based studies have not demonstrated
an association between silica exposure and risk of autoimmune diseases. This lack of effect may be
due to the limited statistical power of these studies to examine this association or because the
lower- or moderate-level exposures that may be more common in the general population were not
considered. Experimental studies demonstrate that silica can act as an adjuvant to nonspecifically
enhance the immune response. This is one mechanism by which silica might be involved in the
development of autoimmune diseases. Given that several different autoimmune diseases may be
associated with silica dust exposure, silica dust may act to promote or accelerate disease
development, requiring some other factor to break immune tolerance or initiate autoimmunity. The
specific manifestation of this effect may depend on underlying differences in genetic susceptibility
or other environmental exposures. Key words: antineutrophil cytoplasmic antibodies, antinuclear
antibodies, nephritis, rheumatoid arthritis, scleroderma, systemic lupus erythematosus, Wegener
granulomatosis. - Environ Health Perspect 107(suppl 5):793-802 (1999).
http.//ehpnet1.niehs.nih.gov/docs/1999/suppl-5/793-802parks/abstract. html
Little is known about the role ofenvironmental
agents in the development of autoimmune
disease. Many studies illustrate the influence
ofa complex array ofgenetic factors on the
development ofautoimmunity and specific
autoimmune diseases (1-3). However, the
onset ofdisease also appears to require the
occurrence ofchance events in the immune
system or exposure to environmental agents
that may trigger or accelerate the disease
process. Occupational exposure to crystalline
silica dust has been examined as apossible risk
factor with respect to several systemic auto-
immune diseases, including rheumatoid
arthritis (RA), scleroderma (SSc), systemic
lupus erythematosus (SLE), and some ofthe
small vessel vasculitidies (SVV) with renal
involvement (e.g., Wegener granulomatosis
[WG]). This article provides a briefoverview
ofsilica dust exposure, summarizes the evi-
dence from human studies on the possible
association between silica and autoimmune
diseases, and describes the evidence related to
mechanisms that may account for this associa-
tion. Considerations for evaluating these data
anddesigning future studies will be discussed.
Exposure to Silica Dust
Silica or silicon dioxide (SiO2) is an abundant
mineral found in rock, sand, and soil. Silica
primarily exists in its crystalline state as
quartz, which is structurally and chemically
different from amorphous silica (e.g.,
diatomaceous earth); silicates (e.g., talc or
asbestos); and silicone [a polymer containing
silicon ([SiO(CH3)2]n)]. Ubiquitous in the
environment, silica is part ofthe small partic-
ulate fraction of air pollution and may com-
prise a significant fraction ofenvironmental
dust levels in some geographic regions (4,5).
In this review, the term silica dust exposure
refers to occupational exposure to the res-
pirable fraction ofcrystalline silica dust. We
do not consider the literature pertaining to
silicone exposure or speculate about the
effects ofothersilicon-containing materials.
Crystalline silica can be harmful when
inhaled as a dust in the respirable range
(< 5-jm particles). Silicosis, a form ofpul-
monary fibrosis, is a well-known occupational
disease that results from acute or chronichigh-
level exposure to silica or silica-containing
dusts (6-8). Silicosis increases susceptibility to
tuberculosis and other respiratory diseases (6),
and silica has recently been categorized by the
International Agency for Research on Cancer
as aknown human carcinogen (8).
Sources ofExposure
The sources ofoccupational exposure to silica
dust are diverse and include many manufac-
turing and construction processes that use sil-
ica as either a tool or a raw material, as well as
the mining and processing ofsilica-containing
rock (9,10) (Table 1). Manyofthese industries
are traditionally known as the dusty trades.
Somejobs may involve regular contactwith sil-
ica but are not commonly recognized as dusty
trades (e.g., dental technician, chemist, or
sculptor). Silica sand and gravel are used in
road construction and concrete and in the
manufacture ofglass and ceramics, foundry
castings, and abrasives such as sandpaper and
sandblasting materials. Silica sand or flour is
also used as a filler in detergents, paints, plas-
tics, and cements; as a filtering agent for water,
sewage, and food production; and as the pri-
mary component ofsome abrasive cleansers
(e.g., scouringpowder).
The permissible exposure limit (PEL) for
respirable silica dust used by the Occupational
Health and Safety Administration (OSHA) is
approximately 0.10 mg/m3 (8-hr time-
weighted average for quartz) (11,12), which is
twice the recommended exposure limit
([REL]; 0.05 mg/m3) suggested by the
National Institute ofOccupational Safety and
Health to minimize risk ofsilicosis (13).
Approximately 1-3 million people in the
United States work in jobs with potential
exposure to silica, and at least 10% ofthese
workers may have dangerously high exposures
(at least 2-10 times the REL) (14). The
National Occupational Exposure Survey
(1981-1983) estimated that women comprise
approximately 20% ofworkers in the United
States with potential silica exposure (15). This
number may increase as more women move
into occupations traditionally held by men.
Recently, the burden ofsilica-related disease
has shifted from industrialized to developing
countries (16).
This article is based on a presentation at the Workshop
on Linking Environmental Agents and Autoimmune
Diseases held 1-3 September 1998 in Research
Triangle Park, North Carolina.
Address correspondence to C. Parks, Epidemiology
Branch, National Institute of Environmental Health
Sciences, MD A3-05, PO Box 12233, Research
Triangle Park, NC 27709. Telephone: (919) 541-3445.
Fax: (919) 541-2511. E-mail: parks@niehs.nih.gov
Work conducted by C. Parks and G. Cooper is
supported through the Intramural Research Program at
the National Institute of Environmental Health Sciences.
K. Conrad's work was supported by the Saxon Ministry
for Science and Art (Sachsisches Ministerium fur
Wissenschaft und Kunst), AZ 4-7541.82-0450/405, and
is currently supported by the Federal Institute for
Occupational Safety and Health, Department of
Occupational Health, Berlin, project no. 1267.
Received 8 February 1999; accepted 28 May 1999.
Environmental Health Perspectives * Vol 107, Supplement 5 * October 1999 793PARKS ETAL.
Table 1. Industries, occupations, and tasks with crystalline silica exposure.a
Industry/occupation
Abrasives
Agriculture
Agricultural chemicals
Asphalt and roofing felt
Automobile repair
Boiler scaling
Cement
Ceramics
Construction
Dental material
Foundries
Glass, fiberglass
Iron, steel mills
Jewelry
Metal
Mining, milling
Paint
Quarrying, milling
Rubber and plastics
Shipbuilding, repair
Silicon, ferro-silicon
Soaps, cosmetics
Specific tasks
Silicon carbide production; abrasive products fabrication
Mechanized plowing, harvesting; sorting, cleaning, grading
Raw material crushing, handling
Filling and granule application
Abrasive blasting
Clean ash and mineral deposits from coal-fired boilers
Materials processing: clay, sand, limestone, diatomaceous earth
Mixing, molding, glaze or enamel spraying, finishing
Abrasive blasting; highway and tunnel construction; excavation/earth moving;
masonry, concrete work, demolition
Abrasive blasting, polishing
Casting, shaking-out; abrasive blasting, felting; furnace installation and repair
Raw material processing (sand, quartz); refractory installation and repair
Refractory preparation and furnace repair
Cutting, grinding, polishing, buffing (gems, stones)
Abrasive blasting (structural, machinery, transportation equipment)
Most occupations and mines (ores, associated rock)
Raw materials handling (fillers)
Stone, sand, gravel processing; stone cutting and abrasive blasting; slatework;
diatomite calcination
Raw materials handling (fillers)
Abrasive blasting
Raw materials handling (sand)
Abrasive soaps, scouring powders
&Data from the International Agency for Research on Cancer(9).
The potential for silica dust exposure in
agriculture was recently recognized by OSHA
based on measurements in some food-
processing operations (17). The levels ofsil-
ica exposure in farming depend on the tasks
and crops involved (18-22) and may also
vary by soil characteristics and quartz content
(23). Exposures as high as 0.10-0.65 mg/m3
(1-6.5 times greater than PEL for silica expo-
sure in other industries) have been reported
in mechanized and manual harvesting of
some crops (18,22). Approximately 10 mil-
lion people in the United States work on a
farm (18). The impact ofsilica dust exposure
in agriculture could be substantial, but rela-
tively few studies have characterized exposure
levels and associated risks in this population.
Silica Dust and Autoimmune
Disease
Initial hypotheses linking silica dust exposure
(or silicosis) to autoimmune diseases were
based on numerous case reports and small
occupationally based case series (24-26).
Larger clinic-based case-series, occupational
cohort, registry-linkage, and case-control
studies have also been conducted, many of
them published since 1995 (27-56). The dis-
eases that have been examined most often
include SSc (24,25,27-43), RA (26,31-33,
35,37,44-46), SLE (29,33,35, 37,47-52),
and some ofthe SVV with renal involvement
(53-56). The population prevalence ofthese
diseases differs by several orders ofmagnitude;
RA is the most common (approximately 1 case
per 100) (57,58), compared to SLE (approxi-
mately 5 cases per 10,000) (58,59) and to SSc
and WG (fewer than 5 cases per 100,000)
(58,60-62). High-level silica exposure has also
been reported in cases of autoimmune
hemolytic anemia, dermatomyositis, vasculitis,
Sjogren syndrome, and Graves disease
(37,63-66). A strong association between sil-
ica dust exposure and sarcoidosis was recently
described (67). Sarcoidosis is an inflam-
matory condition ofthe lung that sometimes
co-exists with or resembles several of the
autoimmune diseases.
Studies that examine the occurrence of
autoimmune disease in occupational cohorts
exposed to silica dust are described in Table
2. Occupational groups studied include min-
ers (25-28,30,32,44,45), graniteworkers and
stonemasons (24,46), andworkers in a scour-
ing powder factory (29). These studies
include clinical descriptions ofsilica-exposed
cases, estimates ofthe incidence or prevalence
in exposed workers, case-control comparisons
within an occupational cohort, or compar-
isons with disease rates in the general popula-
tion. Estimates and comparisons in these
studies often require several assumptions and
inferences about the number ofworkers
exposed and at risk, and the study base may
be difficult to define. Although manyautoim-
mune diseases predominately affect women,
the majority ofworkers studied thus far have
been male, with the exception ofthe scouring
powder factoryworkers in Spain (29).
Table 3 summarizes several registry-linkage
studies ofsilica dust exposure or silicosis and
autoimmune diseases (31-35,46). These
studies areoften population based and typically
use mortality or hospital-based registries to
identify occupational groups and patients
diagnosed withsiicosis orautoimmunedisease.
The larger case-series studies that describe
the prevalence ofsilica dust exposure among
patients with autoimmune disease are pre-
sented in Table 4 (36-39). In these studies,
the majority ofcases are men with recognized
silica dust exposure.
Several recent case-control studies have
examined the association ofsilica dust expo-
sure with SSc and some of the SVV with
renal involvement (40-43,53-56) (Table 5).
Because ofthe low prevalence ofoccupational
silica dust exposure in the general population
(especially in women), most ofthese studies
lacked the statistical power to detect moder-
ate or smaller effects. Despite these limita-
tions, three small studies reported a strong
and significant association ofsilica dust expo-
sure with some ofthe SVV (54:-56).
The following is a summary of the
evidence pertaining to specificdiseases.
Sderoderma
Bramwell first described the occurrence of
SSc in a study ofScottish stonemasons (24).
In the mid-1950s, Erasmus reported an ele-
vated incidence ofSSc in white SouthAfrican
gold miners (25) (Table 2). The coincidence
ofSSc with silicosis is sometimes referred to
as Erasmussyndrome.
Two studies from the mid-1980s provide
additional data on SSc in South African min-
ers (Table 2) (27,28). In white gold miners,
there was a significant difference in cumula-
tive lifetime silica dust exposure between cases
and controls that was explained bydifferences
in exposure intensity rather than duration
(27). A study ofblack gold miners revealed
an excess ofnew SSc cases over the expected
rate in the general population but no differ-
ence in the length of exposure comparing
cases and controls (28). There was no rela-
tion between silicosis and SSc in either of
these studies. Increased occurrence ofSScwas
also reported in a recent study ofscouring
powder manufacturers in Spain (29) and in
approximately 250,000 highly exposed ura-
nium miners in East Germany (30) (Table
2). In the uranium miners, the incidence of
SSc was much higher in workers with silicosis
compared to other workers with high-level
exposure.
Five registry-linkage studies have
examined the incidence or prevalence ofSSc
in silicosis patients (31-35) (Table 3). One
ofthe largerstudies reported a strong and sta-
tistically significant association between sili-
cosis and SSc (risk ratio [RR] = 37.0; 95%
confidence interval [CI], 11.9-86.3) (33). In
contrast, no association between SSc and
occupation was seen in a mortality study in
the United States (34). The occupation data
in this studywere based on information from
death certificates. The relatively small risk for
silicosis-related mortality observed in this
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study (odds ratio [OR] = 2.1 in men) suggests
potential misclassification ofsilica exposure,
since the expected number ofsilicosis-deaths
in the reference group should approach zero.
Three clinic-based studies of SSc have
reported a high prevalence ofsilica exposure in
male patients (36,38,39) but not in other pop-
ulations or in women (37,39) (Table 4). The
results ofcase-control studies on silica dust
exposure and SSc are equivocal (36,40-43)
(Table 5). Adinic-based study in Italy reported
an elevated but nonsignificant OR for silica
dust exposure in men (OR = 5.2; 95% CI,
0.5-74.1) but had extremely limited power,
with only 5 cases and 10 controls (41). None
of the 16 female cases in this study were
exposed to silica dust, compared to 1 ofthe 32
female controls. A slightly elevated but
nonsignificant association for work with or
around silica dust was reported in a large
population-based study of female SSc
patients in Michigan (42). This study was
replicated in Ohio with negative findings for
all silica-related occupations except for work
in sculpting and pottery making (OR = 2.1;
95% CI, 1.1-4.1) (43).
RheumatoidArthritis
Rheumatoid features in the lung associatedwith
silica dust exposure are commonly known as
Caplan syndrome. In the 1950s, Caplan
described unusual radiologic changes in the
lungs of a group ofWelsh coal miners diag-
nosed with pneumoconiosis (26) (Table 2). A
subsequent epidemiologic study in this popula-
tion reported that rheumatoid lesions in the
lung were predictive of a diagnosis of RA in
men with massive pulmonary fibrosis (44)
(Table 2). In South African gold miners, RA
was associatedwithsilicosis (OR = 3.8; 95% CI,
Table 2. Studies ofautoimmune disease in occupational cohorts with silica dust exposure.
Author(ref)
Location Methodsa Disease Majorfindingsb
Caplan, 1953126) Case-series (1950-1952) RA 51 cases described
Erasmus, 1957 (25)
South Africa
Miall et al., 1958 (44)
South Wales
Sluis-Cremer et al., 1985 (27)
South Africa
Sluis-Cremer et al., 1986 (45)
South Africa
Cowie, 1987 (28)
South Africa
Sanchez-Roman et al., 1993 (29)
Spain
Conrad et al., 1995(52)
Eastern Germany
Mehlhorn et al., 1999 (30)
Eastern Germany
Coal miners (male)
14,000 claims for pneumoconiosis
Case-series (1954-1956)
40,013 gold miners (white, male)
Disease prevalence (years not specified)
Coal miners (male) with pneumoconiosis, including
788 PMF patients
20 PMF patients with rheumatoid lesions in the lung
Comparison: 60 age-matched PMF cases without
rheumatoid lesions in the lung
Case-control (1955-1984)
Gold miners (white, male)
79 cases
79 age-matched controls
Exposure: employee records and
dust monitoring data by occupation
Prevalence (1960-1969)
Members ofthe Mines Benefit Society
Comparison: railway, harborworkers
Case-control (1967-1979)
Gold miners (white, male)
157 cases (91 definite, 66 probable)
157 age-matched controls
Exposure: employee records and
dust monitoring data by occupation
Incidence (1981-1986)
Gold miners (black, male)
24,450 ages 33-57 (per year)
Comparison: 486 age-matched miners
Exposure: history by questionnaire
Prevalence (dates not specified - 10 years)
300 scouring powderfactory workers
Sample: 50 volunteers (88% female)
Prevalence (1972-1994)
300,000 uranium miners (male)
30,000 heavily exposed miners
Comparison 1: 102 idiopathic cases
from general population (90% women)
Comparison 2: miners without SLE
Exposure: case histories and occupational
history reports; heavy exposure > 20 mg/m3
Incidence (1966-1995)
Uranium miners (male)
243,900 highly exposed, including
12,400 cases silicosis; 50,000 low exposed
Comparison: estimated population rates
of silicosis and SSc (0.2 cases per 100,000 P-Y)
SSc
RA
SSc
RA
SSc
SSc
SLE
SLE/SSc
SLE
SSc
17 cases described
Incidence = 0.04% (18 months)
Rheumatoid lesions: 4 cases RA (55%)
No rheumatoid lesions: 2 cases RA(3%)
Difference in cumulative exposure*
explained by differences in intensity**
SSc and silicosis: OR = 1.2 (0.3-5.4)
Gold miners: 28 cases (7.7 per 100,000)
Railway/harbor workers: 3 cases
(0.33 per 100,000)
Definite RA and silicosis: OR = 3.8 (1.7-8.4)**
Probable RA and silicosis: OR = 1.9(0.8-4.6)
No difference in cumulative exposure
or intensity
10 cases (8.2 per 100,000 P-Y)
No difference in percent with silicosis,
exposure years, or intensity
SSc: 5 cases (1,667 per 100,000)
SLE: 3 cases (1,000 cases per 100,000)
SLE/SSc: 5 cases (1,667 per 100,000)
Definite SLE: 28 cases (93 per 100,000)
Probable SLE: 15 cases
Arthritis*** and photosensitivity* less
frequent in miners with SLE
Antinuclear antibodies related to
exposure levels and clinical features
Total high: 94 cases; RR = 7.8(6.5-9.5)
With silicosis: 60 cases; RR = 97 (75-125)
Without silicosis: 34 cases; RR = 3.1 (2.2-4.3)
Total low: 3 cases; RR = 1.2 (not significant)
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South Wales
Abbreviations: OR, odds ratio; PMF, progressive massive fibrosis; P-Y, person-years; RA, rheumatoid arthritis; RR, risk ratio; SLE, systemic lupus erythematosus; SSc, scieroderma. 'Description of study
design, source population and size(ifapplicable), study sample and size, and comparison group(ifapplicable). bincludes estimated disease rate or effect measure and 95% confidence interval (in parenthe-
ses) if available. *p< 0.05; **p< 0.001; ***p< 0.0001.
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Table 3. Registry-linkage studies ofoccupational silica dust exposure orsilicosis and autoimmune diseases.
Author(ref)
Location Methodsa Disease Majorfindingsb
Klockars etal., 1987(46) Incidence(1949-1981) and prevalence(1981) RA Disability pensions: RR = 5.08(3.31-7.79)
Finland 1,026 male granite workers (hired 1940-1971) Pensions: 10 cases (1.6expected)*
Registry of RA-specific disability pensions and medications Medications: 19 cases(7.5expected)*
Comparison: men in population
Exposure: granite work 23 months
Rosenman and Zhu, 1995(31) Hospital discharge diagnoses (1990-1991) RA RA and silicosis (men): SIR =3.2(1.1-9.4)
U.S., Michigan Patients diagnosed with pneumoconiosis: 160 silicosis SSc RA and silicosis (women): no cases
(155 men, 5 women), 355 coal worker's pneumoconiosis, RA and unspecified (men): SIR =8.4(2.3-30.4)
252 asbestosis, 12 unspecified dust, 51 unspecified SSc and pneumoconiosis (all): no cases
Comparison: all otherdischarges
Steenland and Brown, 1995(32) Mortality(1940-1990) ART Arthritis (including HA): SMR = 2.2(1.3-3.5)
U.S., South Dakota 3,328 male gold miners MSK MSK(including SLE and SSc): SMR = 2.1 (1.0-3.9)
Multiple-cause mortality listing Skin Skin (including SLE and SSc): SMR = 2.4(1.2-4.5)
Comparison: South Dakota population
Brown et al., 1997 (33) Mortality(1963-1989; Sweden) MSK SMR = 5.9 (2.2-12.5), due to 6 cases of
Sweden, Denmark 1,130 men with silicosis autoimmune disease(including 3 RA, 2 SLE)
Comparison: entire population
Hospital discharge diagnoses in Sweden SSc SSc: 5 cases: RR =37.0(11.9-86.3) Sweden
(1965-1983) and Denmark (1977-1989) SLE SLE: 8 cases: RR =23.8(10.3-47.0) Sweden
Discharge diagnosis of silicosis RA RA: 44 cases: RR = 8.1 (5.9-10.9) Sweden
Comparison: all other discharge diagnoses RA: 10 casesHR = 8.3 (4.0-15.3) Denmark
Walsh, 1997 (34) Mortality (1985-1992) SSc SSc (in men): OR = 1.0(0.8-1.2)
U.S. Death certificates from 25 states Silicosis SSc(in women): OR =0.8(0.6-1.2)
Death from SSc orfrom silicosis Silicosis (in men): OR =2.1 1.9-2.3)
Exposure: 37 occupational groups Silicosis (in women): OR = 8.7 (3.2-19.0)
Comparison: other occupations
Rosenman et al., 1999(35) Disease prevalence (1985-1995) RA RA: 24cases (5.2%): OR =2.7(1.7-4.1)
U.S., Michigan 463 silicosis cases from state registry system SSc SSc: 1 case(0.2%): OR = 15.6(0.2-87.0)
Medical records review and questionnaire SLE SLE: 1 case(0.2%): OR = 11.4(0.2-63.2)
Comparison: rates in the general population
Abbreviations: ART, arthritis; MSK, musculoskeletal disease; OR, odds ratio; RA, rheumatoid arthritis; RR, risk ratio; SIR, standardized incidence ratio; SLE, systemic lupus erythematosus; SMR, standard-
ized mortality ratio; SSc, scleroderma. "Includes description of study design and registries used (source of cases and/or comparison group). bincludes percent, and OR, RR, SMR, or SIR with 95% confi-
dence interval in parentheses when available. *p. 0.001.
1.7-8.4), and there was asignificant increase in
the intensity ofsilica exposure experienced by
casescompared tocontrols(45) (Table2).
Three registry-linkage studies reported sig-
nificantly increased rates ofRA in male siicosis
patients (31,33,35), with estimated relative
risks between 2.7 and 8.3 (Table 3). Because
they selected on silicosis status or were ofcross-
sectional design, the studies ofsiicosis patients
could not differentiate between two causal sce-
narios: a) either silica dust exposure (as evi-
dencedby the presence ofsiicosis) increases the
likelihood ofdeveloping RA, or b) RA results
in increasedprogression andseverityofsiicosis.
This issue was addressed in alongitudinal study
of 1,026 granite workers in Finland (46). The
study used population-based registries to iden-
tify a 5-foldhigher incidence ofnew disability
awards for RAcompared to the rate in the gen-
eral population. These workers were also more
likely to bediagnosed with RAand be receiving
medications for RA at the end ofthe study
period. Themajority (90%) ofthe 35 RA cases
in this study had chest X rays that were free of
indications ofsilicosis at the time they were
diagnosed with RA. None had evidence of
Caplan syndrome, suggesting that these phe-
nomena may be distinct, and that silicosis is
not a necessary component ofan association
between RAandsilicaexposure.
SystemicLupusErythematosus
Until recently, the evidence relating to silica
exposure and SLE was limited to case reports
(37,47-51), and most described male SLE
patients who were also diagnosedwith silicosis
and had a history ofworking in the dusty
trades industries. Occupational silica exposure
has been observed in few women with SLE
(50), and one young woman was diagnosed
with features ofSLE and silicosis afteryears of
recreational scouringpowderinhalation (51).
Two recent studies in occupational
groups suggest that high-level silica exposure
may be associated with SLE (29,52)
(Table 2). This includes three cases ofSLE
and five SLE/SScoverlap cases in thestudy of
50 scouringpowder factoryworkers (29) and
28 SLE cases identified in a study of30,000
male uranium miners examined for silicosis
(52). Silica exposure levels were very high in
these cohorts. The estimated prevalence of
SLE in both these studies was at least 10
times higher than the expected sex-specific
prevalence in the general population.
Estimates in both ofthese studies require sev-
eral assumptions. For instance, the prevalence
estimate in the scouring powder factory is cal-
culated based on the total number ofworkers
(300) rather than the number in the volun-
teer sample, assuming that there are no cases
among the nonparticipants. In the uranium
miner cohort, disease prevalence is based on
rough estimates ofthe numbers ofemployees
and work histories because ofhigh turnover
rates of employees and limited access to
records in a Soviet-German company during
the cold war. However, this was a time with
high production rates and extremely high
exposures (estimated at 200-1000 times the
current OSHAPEL) (30).
One registry-linkage study in Sweden and
Denmark also reported a strong association
between silica dust exposure and SLE (33)
(Table 3); SLE was more frequentlydiagnosed
in patients with siicosis compared to all other
hospitalized patients (RR = 23.8; 95% CI,
10.3-47.0). To date, no case-control studies
have examined the role ofsilica dust exposure
in thedevelopment ofSLE.
Diseas with RenalInvolvement
Some of the SVV are associated with the
production ofantineutrophil cytoplasmic
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Table 4. Case-series studies describing silica dust exposure in autoimmune disease patients.
Author(ref)
Location Methodsa Disease Majorfindingsb
Rodnan et al., 1967(36) Exposure prevalence (1955-1965) SSc 26 exposed cases (43%)
U.S., Pennsylvania 60 male cases
Exposure: prolonged heavy silica exposure
Exposure prevalence (1955-1965) 20 exposed cases (47%)
43 hospitalized male cases 16 exposed controls (19%)*
86 age-, sex-, and race-matched hospital controls
Exposure: prolonged heavy silica exposure
Hospital discharge diagnoses(1958-1962) 11 male cases, 9 female cases
10 hospitals (Appalachian region) Miners (male): 17 cases per 100,000
Exposure: coal mining Nonminers (male): 6 cases per 100,000
Nonminers (female): 9 cases per 100,000
Koeger et al., 1995(37 Exposure prevalence (1979-1989) SSc SSc: 8 exposed cases (6.7%)
France 764 hospitalized cases, including 118 SSc, 530 RA, and 87 SLE RA RA: 5 exposed cases (1%)
Exposure: assessment ofjobs held 2 3 years SLE SLE: 4 exposed cases (4.6%)
Ziegler et al., 1997(38) Exposure prevalence (1971-1991) SSc 24(44%) exposed to dust> 20% quartz
Eastern Germany 54 male SSc cases (not uranium miners) 5(9%) exposed to dust <5% quartz
Comparison: population estimates of exposure prevalence Overall: OR = 10.4(6.1-17.8)
(< 10%), and silicosis(< 1%) With silicosis: OR = 25.3 (13.0-49.1)
Exposure: assessment ofjob history Without silicosis: OR = 6.2 (3.4-11.5)
Haustein andAnderegg, 1998(39) Exposure prevalence (1980-1997) SSc Male cases: 111 (81%)exposed
Eastern Germany 137 male and 454 female cases Female cases: 7(1.5%) exposed
Exposure: self-reported history of silica-related jobs held .6 months
Abbreviations: OR, odds ratio; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SSc, scleroderma. &lncludes description ofstudydesign, studysample (origin and numberofcases), comparison
group(ifany), and exposure classification method. In this context, assessment refers to an expert review ofjob histories for potential silica exposure. Self-reported exposures are those responses to spe-
cific questions on silica-related jobs, often notconfirmed by expert review. b%ncludes percentexposed, and OR or risk ratioswith 95% confidence interval in parentheseswhen available. *p< 0.01.
Table 5. Case-control studies of silica dust exposure, scleroderma, and autoimmune diseases with renal involvement.
Author(ref)
Location Methodsa Disease Majorfindingsb
Silman and Jones, 1992 (40) Clinic-based (dates not specified) SSc No cases with probable silica exposure
United Kingdom 56 male cases 2 cases with possible silica exposure
56 age- and sex-matched clinic-controls Clinic controls: OR =1.0(0.1-7.2)
41 age- and sex-matched friend-controls Friend controls: OR = 1.4(0.1-16.1)
Exposure: assessment of jobs (length not specified)
and self-reported exposures
Gregorini etal., 1993(54) Clinic-based (1987-1992) RPGN: OR = 14)1.7-113.8)"*
Italy 16 male cases ANCA+
32 age- and sex-matched hospital controls (other nephritis patients)
Exposure: assessment ofjobs held 26 months
Bovenzi etal., 1995(41) Clinic-based (1976-1991) SSc Men: OR= 5.2(0.48-74.1)
Italy 21 cases (5 men, 16 women) Women: no exposed cases
42 age- and sex-matched hospital controls
Exposure: assessment of all jobs held . 6 months
Nuyts, 1995(55) Clinic- and population-based (1991-1993) Nephritis: OR = 5.0(1.4-11.6)
Belgium 16 cases (13 men, 3 women) WG
32 age-, sex-, and region-matched population controls
Exposure: assessment of all jobs (length not specified)
Burns etal. 1996(42) Population-based (1985-1991) SSc Working with/around silica:
U.S., Michigan 274 female cases OR = 1.5(0.7-2.9)
1,184 age-, sex-, race-, and region-matched controls Grinding, pottery, dental lab:
Exposure: assessment of specific silica-related jobs held .3 months / OR = 1.2(0.8-1.9)
history of jobs held >5 years
Lacey etal., 1997(43) Population-based (1985-1992) SSc Sculpting/pottery: OR = 2.1 (1.1-4.1)
U.S., Ohio 198 female cases Sandblasting/grinding: OR = 1.3(0.4-3.9)
1,043 age, sex-, race-, and region-matched controls
Exposure: assessment ofjobs held 2 3 months
Satterly etal., 1998(56) Clinic-based Nephritis: ANCA+ nephritis: OR = 12.0 (p= .0055)
Southeastern U.S. 41 cases ANCA+; 19 SLE cases ANCA+ Lupus nephritis: OR = 0.5 (p=0.99)
50 age-, sex-, and race-matched hospital controls (othernephritiscases) SLE
Exposure: self-reported history ofspecific silica-related jobs held 2 1 year
Abbreviations: ANCA, antineutrophil cytoplasmic antibodies; OR, odds ratio; RA, rheumatoid arthritis; RPGN, rapidlyprogressiveglomerulonephritis; SLE, systemic lupus erythematosus; SSc, scleroderma.
WG, Wegener granulomatosis;: Includes description of study design, studysample (origin and number of cases and controls), and exposure classification method. In this context, assessment refers to an
expert review ofjob histories for potential silica exposure. Self-reported exposures are those responses to specific questions on silica-related jobs, often not confirmed by expert review. bInclude OR and
95% confidence interval in parentheses when available. *p<0.01; **p< 0.001.
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autoantibodies (ANCA) (e.g., WG and
microscopic polyangitis) and can involve both
systemic effects and organ-specific pathology,
including the kidney. Evidence suggesting an
association between silica exposure and
ANCA-associated SVV has been recently
reviewed by Gregorini et al. (53). Three
case-control studies show strong and statisti-
cally significant associations between silica
exposure and ANCA-associated SVV with
renal involvement (54-56) (Table 5). Silica
exposure may also be linked with ANCA
reactivity in uranium miners (68). Nearly
10% of243 miners with proteinuria had ele-
vated ANCA levels, compared to 5% of
1,527 miners without proteinuria. Antibodies
against myeloperoxidase (MPO-ANCA) or
proteinase 3 (PR3-ANCA)were detected in
3.3% ofthe group with proteinuriacompared
to 0.07% of those without proteinuria. In
another study, MPO-ANCA were detected in
27% ofsilica-exposed individuals with and
without autoimmune disease (69). The asso-
ciation between ANCA reactivity and silica
exposure, aswell as its relation to the develop-
ment and pathology ofautoimmune diseases,
will require furtherelucidation.
An association between silica exposure and
nephritis has been suggested by registry-
linkage and occupational cohort studies
(70-72), including one that describes
dose-response association ofsilica with end-
stage nonmalignant renal disease in gold min-
ers (72). None of these studies specifically
focused on autoimmune diseases. There are
case reports of lupus nephritis in some
patients with silicosis and cases ofrenal failure
in silica-exposed patients who experienced
clinical manifestations ofconnective tissue dis-
ease (73,74). However, one clinic-based
case-control study found no association
between silica exposure and lupus nephritis
(56). Other silica-exposed cases ofrenal dis-
ease show negative or nonspecific immuno-
logic findings (74). In sum, the causes ofrenal
disease related to silica exposure appear to be
diverse, and the proportion that may be asso-
ciatedwith autoimmune diseases is unknown.
ImmuneAbnormalities
Silicosis and mineral dust pneumoconiosis
have been linked to increased levels ofautoan-
tibodies, immune complexes, and excess pro-
duction ofimmunoglobulins (primarily IgG)
(65,75-79), even in the absence ofdinical fea-
tures ofspecific autoimmune diseases. In a
study of39 sandblasters with silicosis, 44%
were positive forantinuclear antibodies (ANA)
compared to 2-3% of a random sample of
healthy controls (75). Similarly, 34% of 156
coal minerswith pneumoconiosis from various
regions ofthe north-central United Stateswere
ANA positive (76), and the proportion of
ANApositivitywas related to the silica content
of the dust produced by different mines.
Because these studies did not examine the rela-
tion between time ofexposure and autoanti-
body levels, it is unclear whether autoantibody
production in silica-exposed workers is predic-
tive ofthe development of an autoimmune
disease and ifso, what threshold might exist
between this process anddisease onset.
Serology studies of the uranium miner
cohort previously described (79,80) indicate
that miners without autoimmune disease had
a significantly higher frequency ofautoanti-
bodies specific to connective tissue disease
(e.g., anticentromere, anti-topoisomerase,
anti-double-stranded DNA (dsDNA), anti-
Ro/SSA, anti-La/SSB) compared to gender-
and age-matched controls from the general
population. There was an association between
the intensity ofsilica exposure and the expres-
sion of autoantibodies, but there was no
apparent relation between autoantibody
expression and silicosis. After 2-11 years of
follow-up, miners expressing scleroderma-
specific autoantibodies were more likely to
develop scleroderma then autoantibody-
negative miners (80). Disease progression was
also observed in two miners with SLE-specific
autoantibodies (both miners had dsDNA
autoantibodies carrying the 16/6 idiotype)
(81). Evaluating the predictive value of
disease-specific autoantibodies is limited by
the long latency period observed between sil-
ica exposure and the manifestation ofautoim-
mune diseases and by loss to follow-up of
workers who die ofother age-related diseases.
Biologic Mechanism ofSilica
in Autoimmune Disease
Many cases ofautoimmune disease in silica-
exposed individuals have been identified dur-
ing screening or treatment for silicosis. It is
unclear whether silicosis is simply a marker
for high-level silica dust exposure in these
cases or whether it represents a pathologic
process that may predispose some individuals
to the development ofautoimmune disease.
Conversely, it is possible that autoimmune
disease may predispose some individuals to
develop silicosis. Because of the chronic
nature of both conditions, it is difficult to
establish their temporal relationship.
The development ofsilicosis is thought to
involve the ingestion ofsilica particles by
alveolar macrophages that become stimulated,
resulting in inflammation and the activation
of fibroblasts (7). Crystalline silica is
extremely toxic to cells, and silica particles
cannot be broken down by lysozymal
enzymes. Thus, macrophages can be
destroyed by internalized silica, and the
process may repeat itself, resulting in a focal
point ofimmune activity and fibrosis. In this
way, silicosis can be thought ofas a chronic
process ofimmune stimulation.
In humans with high-level exposure, there
is evidence that silica can be mobilized from
the lung to other organs, including lymph
nodes, spleen, and kidney (82). A recent
study in rats demonstrated profound patho-
logic changes in the pulmonary lymph nodes
after silica dust exposure, induding the devel-
opment ofmacrophage granulomas without
fibrosis (83). The early impact on lymphoid
organs reported in this study may in part
explain the immune abnormalities associated
with silica dust exposure.
AdjuvantEllect
Silicahas long been known to have an adjuvant
effect on antibody production (84). An adju-
vant is a substance that nonspecifically
enhances or potentiates an immune response
to an antigen. Although the mechanism by
which silica acts as an adjuvant is not fully
understood, it appears to be related to the
inflammatory response (85). One theory is
that the activation ofmacrophages at the site
ofsilica deposition may lead to increased anti-
gen processing and accelerated antibody pro-
duction. Macrophages respond to internalized
silica by up regulating cytokine production
(including interleukin (IL)-1 and tumor
necrosis factor [TNF]) (86,87), which stimu-
lates other cells and enhances the inflamma-
tory response. IL-1 can activate the T-helper
cells that facilitate B-cell production ofanti-
bodies. In one study, silica was reported to
stimulate the polyclonal (nonspecific)
activation ofhuman T cells in vitro (88), sug-
gesting the potential ofsilica to act as a super-
antigen in vivo. Silica may also activate
immune processes through the release of
reactive oxygen and nitrogen species (89,90).
An adjuvant effect is consistent with the
hypothesis that silica may act to promote the
development of autoimmune diseases,
requiring some other event or process to
break tolerance and initiate autoimmunity.
In experimental models, an immunologic
adjuvant is often mixed with antigen to pro-
duce autoimmune disease. One study
reported that silica enhanced the effects of
neural antigen in an animal model ofmulti-
ple sclerosis (allergic encephalomyelitis); sil-
ica increased the incidence and severity of
disease and advanced the onset of disease
when administered both concurrent and 1
month prior to injection ofthe autoantigen
(91). In this study, silica had both immedi-
ate and latent effects, suggesting that future
studies of silica and autoimmune diseases
may need to consider a wide range ofoppor-
tunities for exposure.
We know of no published studies that
describe a dose-response or threshold effect
for silica as an adjuvant. However, the inflam-
matory response to silica in models ofsiicosis
are clearly dose dependent, as observed in a
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recently developed murine model ofsilicosis
(92). In this study, the characteristics ofthe
immune response were strain dependent. Of
the four strains chosen for experimentation,
two (NZB and MRL/MpJ) have a propensity
to develop autoimmune pathology resembling
SLE. Both of these strains showed strong
inflammatory responses to silica exposure,
especially the NZB strain, but response char-
acteristics varied between the strains. These
results suggest that genetic differences and sus-
ceptibility to autoimmune disease can modify
the features and extent of inflammatory
pathologydueto silicadust exposure.
OtherEffcts
Silica can cause cell death by apoptosis as well
as necrosis (93). Apoptosis is an active process
involving genetic regulation. Three experimen-
tal studies provide evidence that apoptosis may
be enhanced bysilica (94-96), possibly at lev-
els where no acute toxicity may be detected
(96). However, one human study found that
soluble Fas mRNA was dominantly expressed
by peripheral blood mononucleocytes com-
pared to membranous Fas in silicosis patients
who were free ofthe clinical symptoms of
autoimmune disease (97). Although membra-
nous Fas is required for a Fas-Fas ligand inter-
action to induce apoptosis, soluble Fas can
block apoptosis. Understanding the effects of
silica on the complex processes regulating
apoptosiswill require further research.
TNF-a is one possible mediator oflong-
lasting immune response modifications
through its activity as a cytokine with a broad
range ofproinflammatory, catabolic, and
immunostimmulatory activities. Microsatellite
polymorphisms ofTNF-a have been reported
that correspond to variation in secretion
patterns (98); the TNFa2 allele increased
secretion ofTNF-a by monocytes stimulated
with lipopolysaccharide. In uranium miners
with SSc, the TNFa2 allele was significantly
more prevalent compared to controls and to
idiopathic SSc cases (99). This suggests a
hypothesis that differential regulation of
TNF-a production by macrophages ingesting
silica could be involved in the relation
between silicaexposure and SSc.
Renal andVascularEfficts
The mechanisms ofimmune-mediated kidney
diseases arediverse (100), and their relation to
the other features ofautoimmune diseases is
not fully understood. Silica partides can accu-
mulate in the kidney and lead to immune
stimulation and fibrotic processes similar to
those seen in pulmonary silicosis (82). Silica
also has direct toxic effects on the kidneys in
both animals and humans (101). Thus, the
inflammatory and toxic effects ofsilica may
both be involved in the development ofrenal
pathology in autoimmune diseases.
The mechanisms of renal pathology
appear to differ among the various auto-
immune diseases that may be associated with
silica exposure. In WG, inflammation often
starts in the upper and lower airways but in
most instances leads to the development of
glomerulonephritis (70-80% ofcases experi-
ence kidney involvement) (102). Excessive
exposure to silica dust may play a role in this
process through mechanisms described previ-
ously (74). Although autoantibodies can be
detected in the serum, antibody deposition in
the kidney does not appear to be involved in
the pathology ofWG (102). Conversely, the
circulation ofimmune complexes is thought
to be responsible for the development ofrenal
disease in lupus patients. These underlying
differences in pathology may explain the lack
ofassociation between silica dust and lupus
nephritis described in one study (56) com-
pared to the strong associations with nephritis
in ANCA-associated SVV. Renal disease also
occurs in about 5-15% of SSc and RA
patients (103), but no studies have systemati-
cally examined the association ofsilica expo-
sure and renal involvement in thesediseases.
Vasculitis is also a manifestation ofmany
ofthe autoimmune diseases that may be asso-
ciated with silica exposure, including ANCA-
associated SVV, SLE, RA, and sometimes SSc
(103). Vascular pathology in these diseases
appears to involve the interaction ofwhite
blood cells (induding macrophages) with the
vascular endothelium (104), but it is not
known whether silica plays a direct role in
this process.
Endothelial leukocyte adhesion molecule-1
(ELAM-1) and intercellular adhesion mole-
cule-1 (ICAM-1) may be biomarkers of
vascular injury in silica-exposed uranium
miners with SSc. ELAM-1 levels were ele-
vated in silica-exposed uranium miners com-
pared to those in age- and gender-matched
population controls, and the highest levels
occurred in miners with SSc. Up to 25% of
miners with SSc showed strong elevations of
this molecule in the serum compared to 11%
ofminers without symptoms (105). ELAM-1
is expressed on vascular endothelial cells in
response to cytokines (IL-i, TNF-a). It can
be elevated in serum when these cells are
strongly activated or destroyed (106), as
occurs in several inflammatory and disease
conditions (e.g., sepsis, malignancies, autoim-
mune diseases). ICAM-1 can be induced on
dermal vascular endothelial cells by silica dust
(107). There is no evidence that either
ELAM-1 or ICAM-1 is responsible for the
hypothesized effects of silica on vascular
pathology. Future studies should investigate
whether these molecules may act as disease
mediators and explore their use as biomarkers
tostudy the role ofsilica onvascularpathology
in autoimmune di.seases.
Considerations for
Future Research
CommonThreads among
Silica-AssociatedDiseases
Silica dust exposure may be associated with a
wide range of autoimmune diseases and
immune abnormalities. Although some studies
have explicitly focused on only one disease,
several indicate an increased occurrence of sev-
eral different diseases in the same study popu-
lation (27,29,30,33,35,45,52) (Tables 2, 3).
Many clinical features and some autoanti-
bodies overlap between these diseases (108).
Most share a common systemic component, as
well as more specific manifestations in organs
such as the skin, lung, and kidney. Vascular
disease may be a common underlying pathol-
ogy. Future research may benefit from studies
that examine the effects ofsilica dust exposure
across these various diseases and investigate the
potential for shared mechanisms.
Comparing Silica-Exposed
and Idiopathic Cases of
Auatoimmune Disease
Many ofthe studies described in this review
have compared the clinical features and
autoantibodies of silica-exposed cases of
autoimmune disease with idiopathic cases.
However, it is important to account for dif-
ferences in disease characteristics that might
be related to age and sex. The demographics
of cases may be related to both disease charac-
teristics and the likelihood ofsilica dust expo-
sure, making it more difficult to assess
whether certain features or autoantibodies are
related to silica dust exposure.
One study compared the autoantibodies
and clinical features of28 silica-exposed ura-
nium miners with SLE (all men) with 102
idiopathic SLE cases (-90% women) from the
general population (52) (Table 2). All the sil-
ica-exposed cases in this study were men with
late-onset disease, so the differences in autoan-
tibodies or clinical features might be related to
age or gender. Compared to idiopathic cases,
the uranium miners with SLE showed similar
frequencies of Ro/SSA, La/SSB, and
Cardiolipin antibodies, but less frequently
expressed antibodies to single- and double-
stranded DNA; none expressed antibodies to
snRNP proteins (BB', D, E, F, G or Ul-
RNP). Miners with SLE were also signifi-
cantly less likely to experience arthritis or
photosensitivity than the idiopathic cases.
Studies comparing the serological features of
SLE in men with those in women suggest few
significant differences (109-112). Some
studies have found a lower rate ofdsDNA and
Sm antibodies in older-onset SLE (113-115);
other studies have not, possibly because of
ethnic or methodologic variation (116-118).
Future comparisons of silica-exposed and
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idiopathic autoimmune diseases should chose
an appropriate comparison group and care-
filly ascertain the differences in disease char-
acteristics that maybedue to age orsex.
ueAssesment
Obtaining exposure history by personal
interview or industry records provides only a
proxy for silica dust exposure, but steps can
be taken to reduce exposure misdassification.
Assignment to exposure groups based on
standardized industrial or occupational cod-
ing is most prone to error (119). A more
refined strategy is to use an expert assessment
conducted by an industrial hygienist to con-
firm the potential for exposure (120). This
procedure was used in two large population-
based case-control studies ofSSc in women
(42,43) (Table 5). However, expert assess-
ments were limited to jobs initially classified
into standardized exposure groups and thus
may have missed sources ofsilica exposure
that are more common in women. Self-
reported exposures are morelikely to be influ-
enced by differential recall in case-control
studies but may sometimes provide a more
accurate measure ofexposures not recognized
by an expert assessment (e.g., silica exposure
outside thedustytrades industries).
Although there are considerable data on
high-level occupational exposure to silica dust,
it can be difficult to assess moderate- or lower-
level exposures. Potential for high-level expo-
sure is more easily recognized in jobs and
industries required to meet regulatory stan-
dards for the prevention ofsiicosis. Moderate-
or lower-level exposures may occur in those
industries or occupations not routinely moni-
tored for silica or in those where high rates of
silicosis have notbeen identified. Exposure lev-
els in these jobs may typically fall below the
regulatorylimits (0.10-0.05 mg/m3), but there
may be instances where higher level exposures
occur. Exposure levels depend on the fre-
quencyandduration ofexposure-related activi-
ties and on the concentration ofsilica in
workplace dust. Unfortunately, there is little
measurement data for many jobs and indus-
trieswith potential formoderate- orlowerlevel
silicaexposure.
Some common occupational sources of
silica exposure are poorly characterized and
will require additional data to determine the
actual exposure levels. Women make up a
high proportion ofworkers in many ofthese
jobs. Ifsilica exposure in these occupations is
not considered, an association with autoim-
mune disease in female workers might be
missed. These occupations include farming
(silica may comprise as much as 40-50% of
the respirable fraction ofsome types ofsoil),
the use ofscouring powder (in some cases,
almost entirely silica), and other exposures to
dust and dirt (e.g., textile, janitorial, laundry,
refuse handling). Textile workers may be
exposed to silica as a component ofcotton
dust (121,122), but textile work is not typi-
cally considered in assessments ofsilica expo-
sure. We identified no studies measuring
silica exposure in textile workers, with the
exception ofone study in a Chinese cotton
mill reporting that ambient levels ofsilica
dust exceeded the OSHA PEL during an
early processing stage (123). In 1987, an
increased rate of RA was observed in a
prospective study ofwomen in Finland who
were exposed to raw cotton mill dust (124),
but no subsequent studies of silica and
autoimmune diseases have mentioned textile
workas asource ofsilica exposure.
ExposureCharaterstis and
Confoaunding
Most of the published studies on silica-
exposed autoimmune disease consistently
describe very high levels ofsilica exposure.
However, exposure duration among cases is
more variable. One study suggests that expo-
sure intensity may be more important than
cumulative dose in the development of
autoimmune disease (45) (Table 2). Several
occupational cohort and registry-linkage
studies used silicosis or risk of silicosis to
identify exposed workers (31,33,35,52)
(Tables 2,3) and thus may be limited to only
the most highly exposed cases. Future
research in occupational cohorts should
explore the characteristics ofexposure, such as
cumulative dose, intensity, and timing as they
relate to disease onset. It is very difficult to
measure the exposure levels retrospectively,
even using workplace monitoring data and
employee records. At this time, the only bio-
markers ofsilica exposure are an X-ray diag-
nosis of silicosis or invasive assays that
measure silica in the lungor other organs.
Studying autoimmune diseases in occupa-
tional cohorts with silica exposure is limited
by the rare occurrence ofthese diseases, espe-
cially in men. Population-based studies may
be better able to reflect the effect ofsilica
exposure in people at risk of developing
autoimmune diseases, especially ifthey con-
sider the occurrence ofmoderate- and lower-
level exposures. It will remain difficult to
retrospectively measure exposure in these
studies for the reasons described above.
Multiple concurrent exposures are a
particularproblem in studyingsilicadustexpo-
sure and autoimmune disease. Silica rarely
occurs in pure form in the environment and
may be mixedwith awide range ofother min-
erals. It may be difficult to isolate the effects of
silica. Other particulates with adjuvant activity
include talc, tin, and iron ore dust with rela-
tivelylowsilica content (85,125). Authors ofa
recent case-series study suggested renaming
silica-dust lupus as mineral-dust lupus (50).
Variations in forms and mixtures with
other minerals may impact the toxic or
inflammatory effects offree silica, and quartz
can contain trace impurities that affect its
biologic activity (8). For instance, iron ore in
quartz dust can increase the production of
reactive oxygen species and several measures
ofimmune stimulation (126). Other factors
may impact the effect ofsilica; freshly frac-
tured silica appears to be more reactive than
aged dust (127). Surface area and ability to
bind and present antigen may be related to
the magnitude ofadjuvancy for metal oxides,
indudingsilica (85).
Mixed exposures to silica and other
chemicals can occur in industries where silica
may be only one component ofthe manufac-
turing process. Ifthese other chemicals are
independently associated with autoimmune
diseases, they may confound analyses ofthe
effects ofsilica. For instance, rubber manufac-
turing has the potential forbothsilicaandsol-
vent exposure, and some studies suggest that
solvents may be associated with SSc (40,41).
In addition to silica, uranium miners are also
exposed to radon, radon decay products, and
heavy metals. The relation between these
exposures and autoimmune diseases has not
been established, so it is undear whether they
could confound estimated associations
between silica and autoimmune diseases.
Future studies should consider potential con-
founding and interaction ofsilica's effects
with otherexposures.
SusceptibleSubgoups
Disease heterogeneity and differences in
genetic susceptibility can make it more diffi-
cult to identify associations with environmen-
tal agents. The effect ofa risk factor may be
diluted ifevaluated in aheterogeneous popula-
tion (128). Analyses based on clinical, autoan-
tibody, or genetic subgroups may be one way
to illuminate separate causal pathways and
identifyspecificenvironmental riskfactors.
Significant differences in genes of the
majorhistocompatibiity complexwere found
between SSc patients with silica exposure
compared to idiopathic cases (99), especially
among patients expressing anti-topoisomerase
I antibodies. These data suggest that the asso-
ciation ofsilica and autoimmune diseases
maybemodified bygeneticfactors.
Given that women have higher rates of
many autoimmune diseases compared to
men, it is important to learn ifthey are more
or lessvulnerable to environmental exposures.
Most documented cases of silica-related
autoimmune disease have been male, and
some studies have reported lower estimates of
the association between silica dust and
autoimmune disease in women compared to
men (41-43). The discrepancy between the
apparent effects ofsilica in men and women
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maybe explained bytwo factors: a) Men may
be more likely than women be exposed to
high levels ofsilica dust because they com-
prise the majority ofworkers in the dusty
trades industries. b) Women experience a
higher underlying rate ofmany autoimmune
diseases, so the relative impact ofsilica dust
exposure may be diluted by cases that occur
through other causal pathways. An exposure
that increases the rate ofdisease will have a
larger impact when measured as a ratio of
association (RRor OR) in agroup with a low
underlying rate compared with a group with
a higher underlying rate. For example, sup-
pose that the incidence ofa given disease is 1
case per 1,000 men and 10 cases per 1,000
women. If, for a given level ofsilica dust
exposure, 1 additional case appears in 1,000
people, regardless of sex, the relative risk
would be 2.0 for men but only 1.1 for
women. Thus, exposure would appear to be
related todisease in men but not inwomen.
Limitations and Strengths
Despitethelargeexcessofautoimmunediseases
observed in several occupational cohorts, the
effects ofsilica dust exposure are much more
difficult to study in the general population
where high-level exposures arerare, andmoder-
ate- and lower-level exposures are difficult to
assess and probably widespread. Rare diseases
and rare exposures may result in the lack of
powerto detect moderate associations ordiffer-
ences among subgroups. The misdassification
ofsilica dust exposure and confounding by
other factors maybias the estimated association
ofsilicaandautoimmune disease.
Nonetheless, studies with different designs
in a variety ofexposed occupational groups
suggest an association ofsilica with systemic
autoimmune diseases. The adjuvant effect of
silica is one mechanism by which silica could
be involved in autoimmune disease. These
data suggest that silica mayact to promote the
development ofautoimmune diseases, requir-
ing some other factor to break immune toler-
ance or initiate disease. Unlike known,
nonmodifiable risk factors for autoimmune
diseases (e.g., age, sex, genetics), silica dust
exposure can be reduced through industrial
hygiene and engineering measures. For this
reason, the association between silica and
autoimmune diseases merits furtherstudy.
Future research on the association
between silica and autoimmune diseases
should explore the common threads between
the diseases that may be associated with silica
exposure. Because autoimmune diseases and
high-level silica exposures are rare, both occu-
pational and population-based studies have
their limitations. Studies ofexposure parame-
ters would be most easily conducted in occu-
pational cohorts with extensive exposure
history and monitoring data. Longitudinal
research in these cohorts may also be used to
examine the predictive value of autoant-
ibodies. Improved exposure assessment in
population-based studies will require recogni-
tion of the potential for silica exposure in
women, including moderate- and lower-level
silica exposure. Researchers should also
attempt to assess the potential for mixed
exposures or confounding by other factors.
Finally, experimental models could be used to
investigate the mechanisms by which silica
may operate in autoimmune diseases and to
suggest preventive or treatment strategies.
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